Established on 15th October 2019, Truecos Pharmaceutical Works is a global pharmaceutical company dedicated to innovation, quality, and patient welfare.
TRUECOS PHARMACEUTICAL Works is a global pharmaceutical company. Established 15 OCTOBER 2019, it manufactures Pharmaceutical finished formulation, DIETARY supplements & cosmeceutical Product. The company offers pharmaceuticals in a wide range of dosage forms, including capsules, tablets, ointments, liquids & creams.
The plant is approved by WHO-GMP, AND ISO 9001-2015 CERTIFIED COMPANY. We adjust and adapt to the changing needs of our customers and remain dedicated in our efforts to save them to the best of our ability.
Develop the most competitive and focused pipeline to address unmet patient needs in a highly differentiated way to drive the growth of Truecos. We are committed to bringing innovative products for the healthcare professional to improve the health and well being of individuals.
At the heart of truecos, our guiding values support us as we deliver on our vision to be the most indispensable medicines company for the world. Truecos values embody the very nature of how we operate.
When truecos was founded, our goal was to provide patients with access to affordable healthcare as our company has grown into one of the world’s leading healthcare companies, our dedication to patients remains steadfast.
Governs our commitment to making safe, quality products for our patients in a manner that fully complies with applicable laws and regulations.
Detailed guidance for complying with anti-corruption and anti-bribery laws
applicable to our businesses
worldwide.
Critical to the successful operation of a healthcare company, integrated seamlessly into our corporate culture and decision-making.
Quality permeates everything we do at Truecos — from R&D and production development to vendor selection and after-market support.
Two decades of growth, innovation, and global expansion.
Truecos Pharmaceuticals incorporated in Ahmedabad, Gujarat with a focus on quality generic medicines.
Commenced international operations, exporting to 10 countries across South Asia and Africa.
Received first USFDA approval for manufacturing facility. Entered the United States generics market.
Inaugurated state-of-the-art R&D centre with 500+ scientists. Specialty pharma focus initiated.
EMA registration achieved. Products now available in 15 European countries through strategic partnerships.
Serving 50+ countries, 500+ products, 8000+ employees, and a pipeline of innovative specialty therapies.
